Development of Novel Pegylated Imidazobenzodiazepines Targeting α5 GABAA Receptors for Anxiety: A Comparative Prodrug and Metabolite Study.

Toriola MA, Kowalczyk ET, Medubi KM, Meyer MJ, Fernando MRT, Scholze P, Premananda N, Harrington SG, Barkley BR, Webb DA, Arnold LA

Open source

DOI: 10.1021/acschemneuro.6c00222
Published: 2026 Sep 2
Container: ACS chemical neuroscience
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acschemneuro.6c00222,
  title = {Development of Novel Pegylated Imidazobenzodiazepines Targeting α5 GABAA Receptors for Anxiety: A Comparative Prodrug and Metabolite Study.},
  author = {Toriola MA and Kowalczyk ET and Medubi KM and Meyer MJ and Fernando MRT and Scholze P and Premananda N and Harrington SG and Barkley BR and Webb DA and Arnold LA},
  year = {2026},
  journal = {ACS chemical neuroscience},
  doi = {10.1021/acschemneuro.6c00222},
  url = {https://doi.org/10.1021/acschemneuro.6c00222}
}

RIS

TY  - JOUR
TI  - Development of Novel Pegylated Imidazobenzodiazepines Targeting α5 GABAA Receptors for Anxiety: A Comparative Prodrug and Metabolite Study.
AU  - Toriola MA
AU  - Kowalczyk ET
AU  - Medubi KM
AU  - Meyer MJ
AU  - Fernando MRT
AU  - Scholze P
AU  - Premananda N
AU  - Harrington SG
AU  - Barkley BR
AU  - Webb DA
AU  - Arnold LA
PY  - 2026
JO  - ACS chemical neuroscience
DO  - 10.1021/acschemneuro.6c00222
UR  - https://doi.org/10.1021/acschemneuro.6c00222
ER  -

APA

MA, T., ET, K., KM, M., MJ, M., MRT, F., P, S., N, P., SG, H., BR, B., DA, W., & LA, A. (2026). Development of Novel Pegylated Imidazobenzodiazepines Targeting α5 GABAA Receptors for Anxiety: A Comparative Prodrug and Metabolite Study.. ACS chemical neuroscience. https://doi.org/10.1021/acschemneuro.6c00222

Source records

pubmed · retrieved 2026-09-27T00:47:45.779Z